Hum. Reprod. Advance Access originally published online on September 12, 2007
Human Reproduction 2007 22(11):3042; doi:10.1093/humrep/dem290
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Letters to the Editor |
Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome
Infertility and IVF Unit, Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon 78078, Israel
1 Correspondence address. Tel: +972-8-6745932/3; Fax: +972-8-6745134; E-mail: raoulo@barzi.health.gov.il
| The first 10% of the full text of this article appears below. |
Sir,
We read with interest the study by Kosaka et al. (2007)
, on vascular endothelial growth factor (VEGF) production by circulating immune cells in ovarian hyperstimulation syndrome (OHSS) patients.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. A. Vardhana, M. A. Julius, S. V. Pollak, E. G. Lustbader, R. K. Trousdale, and J. W. Lustbader A Unique Human Chorionic Gonadotropin Antagonist Suppresses Ovarian Hyperstimulation Syndrome in Rats Endocrinology, August 1, 2009; 150(8): 3807 - 3814. [Abstract] [Full Text] [PDF] |
||||
